{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"OtherAbstract": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "SpaceFlightMission": [], "KeywordList": [], "InvestigatorList": [], "PMID": "4568395", "DateCompleted": {"Year": "1973", "Month": "04", "Day": "02"}, "DateRevised": {"Year": "2013", "Month": "11", "Day": "21"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "0028-4793", "JournalIssue": {"Volume": "287", "Issue": "20", "PubDate": {"Year": "1972", "Month": "Nov", "Day": "16"}}, "Title": "The New England journal of medicine", "ISOAbbreviation": "N Engl J Med"}, "ArticleTitle": "Medical management of primary hypertension. 2.", "Pagination": {"StartPage": "1018", "EndPage": "1023", "MedlinePgn": "1018-23"}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [], "LastName": "Page", "ForeName": "L B", "Initials": "LB"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Sidd", "ForeName": "J J", "Initials": "JJ"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "N Engl J Med", "NlmUniqueID": "0255562", "ISSNLinking": "0028-4793"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Diuretics"}, {"RegistryNumber": "26NAK24LS8", "NameOfSubstance": "Hydralazine"}, {"RegistryNumber": "56LH93261Y", "NameOfSubstance": "Methyldopa"}], "MeshHeadingList": [{"QualifierName": ["drug effects"], "DescriptorName": "Blood Pressure"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cardiac Output"}, {"QualifierName": ["adverse effects", "pharmacology", "therapeutic use"], "DescriptorName": "Diuretics"}, {"QualifierName": ["drug effects"], "DescriptorName": "Heart Rate"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["adverse effects", "pharmacology", "therapeutic use"], "DescriptorName": "Hydralazine"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Hypertension"}, {"QualifierName": ["adverse effects", "pharmacology", "therapeutic use"], "DescriptorName": "Methyldopa"}, {"QualifierName": [], "DescriptorName": "Phytotherapy"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["drug effects"], "DescriptorName": "Plasma Volume"}, {"QualifierName": ["adverse effects", "pharmacology", "therapeutic use"], "DescriptorName": "Rauwolfia"}, {"QualifierName": ["drug effects"], "DescriptorName": "Regional Blood Flow"}, {"QualifierName": ["drug effects"], "DescriptorName": "Vascular Resistance"}], "NumberOfReferences": "86"}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1972", "Month": "11", "Day": "16"}, {"Year": "1972", "Month": "11", "Day": "16", "Hour": "0", "Minute": "1"}, {"Year": "1972", "Month": "11", "Day": "16", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["4568395", "10.1056/NEJM197211162872005"]}}]}